Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.

Autor: Smith, Benjamin D., Lei, Xiudong, Diao, Kevin, Xu, Ying, Shen, Yu, Smith, Grace L., Giordano, Sharon H., DeSnyder, Sarah M., Hunt, Kelly K., Teshome, Mediget, Jagsi, Reshma, Shaitelman, Simona F., Peterson, Susan K., Swanick, Cameron W.
Zdroj: Annals of Surgical Oncology: An Oncology Journal for Surgeons; Apr2020, Vol. 27 Issue 4, p1013-1022, 10p
Abstrakt: Background: The effect of surgeon factors on patient-reported quality-of-life outcomes after breast-conserving therapy (BCT) is unknown and may help patients make informed care decisions. Methods: We performed a survey study of women aged ≥ 67 years with non-metastatic breast cancer diagnosed in 2009 and treated with guideline-concordant BCT, to determine the association of surgeon factors with patient-reported outcomes. The treating surgeon was identified using Medicare claims, and surgeon factors were identified via the American Medical Association Physician Masterfile. The primary outcome was patient-reported cosmetic satisfaction measured by the Cancer Surveillance and Outcomes Research Team (CanSORT) Satisfaction with Breast Cosmetic Outcome instrument, while secondary outcomes included BREAST-Q subdomains. All patient, treatment, and surgeon covariables were included in a saturated multivariable linear regression model with backward elimination applied until remaining variables were p < 0.1. Results: Of 1650 women randomly selected to receive the questionnaire, 489 responded, of whom 289 underwent BCT. Median age at diagnosis was 72 years and the time from diagnosis to survey was 6 years. The mean adjusted CanSORT score was higher for patients treated by surgical oncologists than patients treated by non-surgical oncologists (4.01 [95% confidence interval [CI] 3.65–4.38] vs. 3.53 [95% CI 3.28–3.77], p = 0.006). Similarly, mean adjusted BREAST-Q Physical Well-Being (91.97 [95% CI 86.13–97.80] vs. 83.04 [95% CI 80.85–85.22], p = 0.006) and Adverse Radiation Effects (95.28 [95% CI 91.25–99.31] vs. 88.90 [95% CI 86.23–91.57], p = 0.004) scores were better among patients treated by surgical oncologists. Conclusions: Specialized surgical oncology training is associated with improved long-term patient-reported outcomes. These findings underscore the value of specialized training and may be useful to patients choosing their care team. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: